Literature DB >> 25473103

CTNND2-a candidate gene for reading problems and mild intellectual disability.

Wolfgang Hofmeister1, Daniel Nilsson2, Alexandra Topa3, Britt-Marie Anderlid4, Fahimeh Darki5, Hans Matsson6, Isabel Tapia Páez6, Torkel Klingberg5, Lena Samuelsson3, Valtteri Wirta7, Francesco Vezzi8, Juha Kere9, Magnus Nordenskjöld4, Elisabeth Syk Lundberg4, Anna Lindstrand4.   

Abstract

BACKGROUND: Cytogenetically visible chromosomal translocations are highly informative as they can pinpoint strong effect genes even in complex genetic disorders. METHODS AND
RESULTS: Here, we report a mother and daughter, both with borderline intelligence and learning problems within the dyslexia spectrum, and two apparently balanced reciprocal translocations: t(1;8)(p22;q24) and t(5;18)(p15;q11). By low coverage mate-pair whole-genome sequencing, we were able to pinpoint the genomic breakpoints to 2 kb intervals. By direct sequencing, we then located the chromosome 5p breakpoint to intron 9 of CTNND2. An additional case with a 163 kb microdeletion exclusively involving CTNND2 was identified with genome-wide array comparative genomic hybridisation. This microdeletion at 5p15.2 is also present in mosaic state in the patient's mother but absent from the healthy siblings. We then investigated the effect of CTNND2 polymorphisms on normal variability and identified a polymorphism (rs2561622) with significant effect on phonological ability and white matter volume in the left frontal lobe, close to cortical regions previously associated with phonological processing. Finally, given the potential role of CTNND2 in neuron motility, we used morpholino knockdown in zebrafish embryos to assess its effects on neuronal migration in vivo. Analysis of the zebrafish forebrain revealed a subpopulation of neurons misplaced between the diencephalon and telencephalon.
CONCLUSIONS: Taken together, our human genetic and in vivo data suggest that defective migration of subpopulations of neuronal cells due to haploinsufficiency of CTNND2 contribute to the cognitive dysfunction in our patients. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Cell biology; Chromosomal; Copy-number; Memory Disorders; Molecular genetics

Mesh:

Substances:

Year:  2014        PMID: 25473103     DOI: 10.1136/jmedgenet-2014-102757

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  16 in total

1.  Whole-Genome Sequencing of Cytogenetically Balanced Chromosome Translocations Identifies Potentially Pathological Gene Disruptions and Highlights the Importance of Microhomology in the Mechanism of Formation.

Authors:  Daniel Nilsson; Maria Pettersson; Peter Gustavsson; Alisa Förster; Wolfgang Hofmeister; Josephine Wincent; Vasilios Zachariadis; Britt-Marie Anderlid; Ann Nordgren; Outi Mäkitie; Valtteri Wirta; Max Käller; Francesco Vezzi; James R Lupski; Magnus Nordenskjöld; Elisabeth Syk Lundberg; Claudia M B Carvalho; Anna Lindstrand
Journal:  Hum Mutat       Date:  2016-12-05       Impact factor: 4.878

Review 2.  Delta-Catenin as a Modulator of Rho GTPases in Neurons.

Authors:  Maxsam S Donta; Yogesh Srivastava; Pierre D McCrea
Journal:  Front Cell Neurosci       Date:  2022-07-04       Impact factor: 6.147

Review 3.  5p deletions: Current knowledge and future directions.

Authors:  Joanne M Nguyen; Krista J Qualmann; Rebecca Okashah; AmySue Reilly; Mikhail F Alexeyev; Dennis J Campbell
Journal:  Am J Med Genet C Semin Med Genet       Date:  2015-08-03       Impact factor: 3.908

Review 4.  Genetic alterations of δ-catenin/NPRAP/Neurojungin (CTNND2): functional implications in complex human diseases.

Authors:  Qun Lu; Byron J Aguilar; Mingchuan Li; Yongguang Jiang; Yan-Hua Chen
Journal:  Hum Genet       Date:  2016-07-05       Impact factor: 4.132

5.  The X-Linked Autism Protein KIAA2022/KIDLIA Regulates Neurite Outgrowth via N-Cadherin and δ-Catenin Signaling.

Authors:  James Gilbert; Heng-Ye Man
Journal:  eNeuro       Date:  2016-10-28

6.  Identification of NCAN as a candidate gene for developmental dyslexia.

Authors:  Elisabet Einarsdottir; Myriam Peyrard-Janvid; Fahimeh Darki; Jetro J Tuulari; Harri Merisaari; Linnea Karlsson; Noora M Scheinin; Jani Saunavaara; Riitta Parkkola; Katri Kantojärvi; Antti-Jussi Ämmälä; Nancy Yiu-Lin Yu; Hans Matsson; Jaana Nopola-Hemmi; Hasse Karlsson; Tiina Paunio; Torkel Klingberg; Eira Leinonen; Juha Kere
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

7.  TIDDIT, an efficient and comprehensive structural variant caller for massive parallel sequencing data.

Authors:  Jesper Eisfeldt; Francesco Vezzi; Pall Olason; Daniel Nilsson; Anna Lindstrand
Journal:  F1000Res       Date:  2017-05-10

8.  High-resolution detection of chromosomal rearrangements in leukemias through mate pair whole genome sequencing.

Authors:  Anh Nhi Tran; Fulya Taylan; Vasilios Zachariadis; Ingegerd Ivanov Öfverholm; Anna Lindstrand; Francesco Vezzi; Britta Lötstedt; Magnus Nordenskjöld; Ann Nordgren; Daniel Nilsson; Gisela Barbany
Journal:  PLoS One       Date:  2018-03-12       Impact factor: 3.240

9.  Novel truncating mutations in CTNND1 cause a dominant craniofacial and cardiac syndrome.

Authors:  Reham Alharatani; Athina Ververi; Ana Beleza-Meireles; Weizhen Ji; Emily Mis; Quinten T Patterson; John N Griffin; Nabina Bhujel; Caitlin A Chang; Abhijit Dixit; Monica Konstantino; Christopher Healy; Sumayyah Hannan; Natsuko Neo; Alex Cash; Dong Li; Elizabeth Bhoj; Elaine H Zackai; Ruth Cleaver; Diana Baralle; Meriel McEntagart; Ruth Newbury-Ecob; Richard Scott; Jane A Hurst; Ping Yee Billie Au; Marie Therese Hosey; Mustafa Khokha; Denise K Marciano; Saquib A Lakhani; Karen J Liu
Journal:  Hum Mol Genet       Date:  2020-07-21       Impact factor: 6.150

10.  Identifying interactive biological pathways associated with reading disability.

Authors:  Hope Sparks Lancaster; Xiaonan Liu; Valentin Dinu; Jing Li
Journal:  Brain Behav       Date:  2020-06-28       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.